Bone Biologics Corp Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bone Biologics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q3 2024.
  • Bone Biologics Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $10K, a 93.8% decline year-over-year.
  • Bone Biologics Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$316K.
  • Bone Biologics Corp annual Nonoperating Income (Expense) for 2023 was $480K, a 78% decline from 2022.
  • Bone Biologics Corp annual Nonoperating Income (Expense) for 2022 was $2.18M.
  • Bone Biologics Corp annual Nonoperating Income (Expense) for 2021 was -$508K, a 49.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$316K $10K -$151K -93.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$165K $25.9K -$1.24M -98% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $1.08M $37.6K +$600K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $480K -$390K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $161K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.27M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$562K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2019 -$260K +$386K +59.8% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q3 2018 -$647K +$598K +48.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q4 2017 -$4.42M -$1.46M +$126K +7.92% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$4.55M -$1.24M -$883K -244% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$3.67M -$957K -$597K -166% Apr 1, 2017 Jun 30, 2017 10-K 2018-04-02
Q1 2017 -$3.07M -$762K +$2.4M +75.9% Jan 1, 2017 Mar 31, 2017 10-K 2018-04-02
Q4 2016 -$5.46M -$1.58M -$1.2M -309% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$4.27M -$362K +$25.2K +6.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-02
Q2 2016 -$4.29M -$360K +$20.3K +5.34% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-02
Q1 2016 -$4.31M -$3.16M -$2.44M -341% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2015 -$1.87M -$388K -$113K -41.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$1.76M -$387K +$490K +55.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$2.25M -$380K -$269K -242% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$1.98M -$717K -$568K -381% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$1.41M -$274K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$878K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$111K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$149K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.